Markets

Sector Update: Health Care

Health-care shares were fairly flat in pre-market trading Tuesday.

Celladon ( CLDN ), a clinical-stage biotechnology company in the field of gene therapy and calcium dysregulation, priced an underwritten public offering of 4 million shares of its common stock at $9.50 per share. CLDN was down 2.5% at $9.41 in pre-market trading.

Insmed ( INSM ) priced an offering of 8.9 million shares of its common stock at a price of $11.25 per share in a registered underwritten public offering for gross proceeds totaling approximately $100 million. Shares of Insmed were down 2.6% in pre-market trading.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

INSM

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More